Astera Labs, Inc. Common Stock
Here’s whether Astera Labs, Inc. Common Stock (ALAB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.
Positives: trading above the 200-day MA (long-term uptrend intact); RSI 40 — healthy momentum range; strong 1-year return of +60.5%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.93% over 10 days); 3-month momentum negative (-7.1%). Currently 43.0% off its 52-week high. Score: +1/7.
ALAB is holding above its long-term 200-day MA ($218.80) but has slipped below the 50-day MA ($350.92), pointing to short-term weakness in an otherwise intact trend. An RSI of 39.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +60.5% compares to +20.5% for SPY (beat the market by 40.0%). The current 43.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.